N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide structure
|
Common Name | N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide | ||
---|---|---|---|---|
CAS Number | 141626-35-9 | Molecular Weight | 322.363 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 518.9±60.0 °C at 760 mmHg | |
Molecular Formula | C12H10N4O3S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 267.6±32.9 °C |
Use of N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMideDebutyldronedarone is a major circulating active metabolite of dronedarone in humans. Dronedarone is a derivative of amiodarone--a popular antiarrhythmic drug. It was developed to overcome the limiting iodine-associated toxicities of amiodarone. |
Name | [[(5Z)-5-(1,3-benzodioxol-5-ylmethylidene)-4-oxo-1,3-thiazol-2-yl]amino]thiourea |
---|---|
Synonym | More Synonyms |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 518.9±60.0 °C at 760 mmHg |
Molecular Formula | C12H10N4O3S2 |
Molecular Weight | 322.363 |
Flash Point | 267.6±32.9 °C |
Exact Mass | 322.019440 |
PSA | 163.39000 |
LogP | 1.95 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.815 |
Hydrazinecarbothioamide, 2-[(5Z)-5-(1,3-benzodioxol-5-ylmethylene)-4,5-dihydro-4-oxo-2-thiazolyl]- |
2-[(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-4-oxo-4,5-dihydro-1,3-thiazol-2-yl]hydrazinecarbothioamide |